Evidence map›Paper›PMID 42857277›Full record

ArticleFood science & nutrition2026

Ginsenoside Rb1 From the Functional Food

Chang-Sheng Dong, Gaoqiang Wang, Ying Niu, Xiuqiao Sun, Wenyi Ren, Jiliang Zhang, Yi Zhang, Rui-Xin Wu, Xiaoxiong Wu

Abstract read
In one paragraph

Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chang-Sheng DongCancer Institute, Department of Oncology Longhua Hospital, Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0000-0001-8385-7904
Gaoqiang WangDepartment of Traditional Chinese Medicine Internal Medicine Shanghai Baoshan Luodian Hospital Shanghai China.ORCID https://orcid.org/0000-0002-6320-9499
Ying NiuShanghai Tenth People's Hospital, Tongji University School of Medicine Shanghai China.
Xiuqiao SunCancer Institute, Department of Oncology Longhua Hospital, Shanghai University of Traditional Chinese Medicine Shanghai China.
Wenyi RenCancer Institute, Department of Oncology Longhua Hospital, Shanghai University of Traditional Chinese Medicine Shanghai China.
Jiliang ZhangFaculty of Chinese Medicine Macau University of Science and Technology Foundation Taipa Macau China.
Yi ZhangPreclinical Department Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine Shanghai China.ORCID https://orcid.org/0000-0001-6555-6614
Rui-Xin WuPreclinical Department Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine Shanghai China.
Xiaoxiong WuDepartment of Traditional Chinese Medicine, Yangpu Hospital, School of Medicine Tongji University Shanghai China.ORCID https://orcid.org/0000-0003-0429-8556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant gastrointestinal tumor, and its nutritional intervention strategies remain relatively limited. Ginseng, a representative medicinal herb officially included in China's "Food and Medicinal Same Origin" catalogue, is widely used in tea beverages, soups, and functional foods. Its active component, ginsenoside Rb1 (GRB1), derived from the medicine-food homology plant

Indexed as

cancer researchfunctional foodginsengmacrophage polarizationnutritional interventionspancreatic cancer

Identifiers

PMID42857277
PMCPMC13650271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.